Risk Factors for Hospital Admissions Associated with Adverse Drug Events

To identify predictors of hospital admissions associated with adverse drug events (ADEs) and to determine the preventability of ADEs in patients admitted to two hospitals.

[1]  Peter P. Morgan,et al.  Compliance in Health Care , 1979 .

[2]  F Y Aoki,et al.  Drug‐Associated Hospital Admissions in Older Medical Patients , 1988, Journal of the American Geriatrics Society.

[3]  C. Hepler,et al.  Opportunities and responsibilities in pharmaceutical care. , 1990, American journal of hospital pharmacy.

[4]  J. Hallas,et al.  Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention , 1990, Journal of internal medicine.

[5]  J. Hallas,et al.  Drug related admissions to medical wards: a population based survey. , 1992, British journal of clinical pharmacology.

[6]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[7]  S D Small,et al.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. , 1995, JAMA.

[8]  Jonathan M. Teich,et al.  Identifying hospital admissions due to adverse drug events using a computer‐based monitor , 2001, AMIA.

[9]  Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[10]  D. Bates,et al.  Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. , 1999, Archives of internal medicine.

[11]  R. Raschetti,et al.  Suspected adverse drug events requiring emergency department visits or hospital admissions , 1999, European Journal of Clinical Pharmacology.

[12]  David W. Bates,et al.  Research Paper: Using Computerized Data to Identify Adverse Drug Events in Outpatients , 2001, J. Am. Medical Informatics Assoc..

[13]  M. Chan,et al.  Adverse drug events as a cause of hospital admission in the elderly , 2001, Internal medicine journal.

[14]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[15]  I. Buajordet,et al.  Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital , 2002, Acta paediatrica.

[16]  D. Mcrobbie,et al.  Identification of medication‐related attendances at an A & E department , 2003, Journal of clinical pharmacy and therapeutics.

[17]  A. Avery,et al.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study , 2003, Quality & safety in health care.

[18]  J. Raboud,et al.  Patient Characteristics Associated with Nonprescription Drug Use in Intentional Overdose , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[19]  Bruce M Greenwald,et al.  Incidence and impact of adverse drug events in pediatric inpatients. , 2003, Archives of pediatrics & adolescent medicine.

[20]  A. Filippelli,et al.  Adverse drug events in two emergency departments in Naples, Italy: an observational study. , 2004, Pharmacological research.

[21]  D. Bates,et al.  Risk Factors for Adverse Drug Events Among Older Adults in the Ambulatory Setting , 2004, Journal of the American Geriatrics Society.

[22]  Alan J. Forster,et al.  Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital , 2004, Canadian Medical Association Journal.

[23]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[24]  G. Trifirò,et al.  Adverse drug events in emergency department population: a prospective Italian study , 2005, Pharmacoepidemiology and drug safety.

[25]  I. Arispe,et al.  Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001. , 2005, Joint Commission journal on quality and patient safety.

[26]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[27]  C. Richards,et al.  Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults , 2007, Annals of Internal Medicine.

[28]  A. Melander,et al.  Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care , 2007, The Annals of pharmacotherapy.

[29]  Nick Barber,et al.  The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines , 2007, Pharmacy World & Science.

[30]  P. Noyce,et al.  Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.

[31]  A. Egberts,et al.  Reliability of the assessment of preventable adverse drug events in daily clinical practice , 2008, Pharmacoepidemiology and drug safety.

[32]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. , 2008, The Journal of pediatrics.

[33]  R. Hingson,et al.  Hospitalizations for alcohol and drug overdoses in young adults ages 18-24 in the United States, 1999-2008: results from the Nationwide Inpatient Sample. , 2011, Journal of studies on alcohol and drugs.

[34]  D. Ashcroft,et al.  Prevalence of Adverse Drug Events in Ambulatory Care: A Systematic Review , 2011, The Annals of pharmacotherapy.

[35]  Jürgen Stausberg,et al.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data , 2011, BMC health services research.

[36]  A. Sheikh,et al.  A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis , 2012, The Lancet.